Skip to content
Moderna logo

Moderna Income Statement

Revenue, expenses, and profitability over time

Moderna generated $2.2B in trailing twelve-month revenue, down 0.3% year-over-year. Net income was -$3.2B with a -143.55% net margin. Gross margin stands at 22.11% and operating margin at -153.35%. Diluted EPS is $-8.15, which grew 0.1% year-over-year. Based on the Q1 2026 filing.

Latest FilingQ1 2026
Report Date2026-05-01
Market Cap$19.7B
ROE-36.56%

Tax

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income tax expense-$64M$7M$7M$13M$27M$9M

Net Income

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Net income-$1.1B-$971M-$825M-$200M-$826M-$1.3B

Revenue

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Total revenue$966M$108M$142M$1B$678M$389M